Pyelonephritis Treatment Guidelines

Introduction to Pyelonephritis

Pyelonephritis, an infection of the renal parenchyma, can lead to impaired renal function and volume depletion, making ketorolac use potentially dangerous 1

The European Urology guidelines recommend ciprofloxacin 500-750 mg twice daily for 7 days as a first-line oral therapy for mild-moderate uncomplicated pyelonephritis cases 1, 2
The European Urology guidelines recommend levofloxacin 750 mg once daily for 5 days as a first-line oral therapy for mild-moderate uncomplicated pyelonephritis cases 1, 3
The Clinical Infectious Diseases guidelines recommend trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days as a first-line oral therapy for mild-moderate uncomplicated pyelonephritis cases, only if susceptibility is known 1, 2
The European Urology guidelines recommend ciprofloxacin 400 mg twice daily as a parenteral therapy for severe pyelonephritis cases requiring hospitalization 1
The European Urology guidelines recommend levofloxacin 750 mg once daily as a parenteral therapy for severe pyelonephritis cases requiring hospitalization 1
The Clinical Infectious Diseases guidelines recommend ceftriaxone 1-2 g once daily as a parenteral therapy for severe pyelonephritis cases requiring hospitalization 1, 2

The European Urology guidelines recommend diagnosis based on fever (>38°C), chills, flank pain, nausea, vomiting, or costovertebral angle tenderness 1
The European Urology guidelines recommend urinalysis to assess for white blood cells, red blood cells, and nitrite 1
The European Urology guidelines recommend ultrasound imaging to rule out urinary tract obstruction or renal stones, particularly in patients with a history of urolithiasis or renal dysfunction 1

The European Urology guidelines recommend reassessing patients if fever persists after 72 hours of appropriate antibiotic therapy 1
The European Urology guidelines recommend additional imaging (contrast-enhanced CT) if clinical status deteriorates or fever persists 1
The Annals of Internal Medicine guidelines recommend treatment duration ranging from 5-14 days depending on the antibiotic used and clinical response 3, 4, 5

The European Urology guidelines recommend avoiding nitrofurantoin, oral fosfomycin, and pivmecillinam for pyelonephritis due to insufficient efficacy data 1
The Annals of Internal Medicine guidelines recommend not using trimethoprim-sulfamethoxazole empirically without culture and susceptibility testing due to high resistance rates 3, 4, 5
The European Urology guidelines recommend reserving carbapenems and novel broad-spectrum antimicrobials for cases with confirmed multidrug-resistant organisms 1